Repeated Application of Gene Therapy in CF Patients

NCT01621867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: pGM169/GL67A
DRUG: Placebo

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]
[object Object]